Healthcare >> CEO Interviews >> October 17, 2003
TODD SIMPSON is Vice President, Finance and Administration, and Chief
Financial Officer of Targeted Genetics Corporation. He joined Targeted
in October 2001. From 1996 through October 2001, Mr. Simpson served as
Vice President, Finance and Administration and Chief Financial Officer
at Aastrom Biosciences, Inc. Prior to that, Mr. Simpson was Treasurer of
Integra LifeSciences Corporation, which acquired Telios Pharmaceuticals,
Inc., in August 1995. Mr. Simpson was Vice President of Finance and
Chief Financial Officer of Telios up until its acquisition by Integra
and held various other financial positions at Telios after joining that
company in 1992. From 1983 to 1992, Mr. Simpson practiced public
accounting with the firm of Ernst & Young, LLP. Mr. Simpson is a
Certified Public Accountant and received his Bachelor of Science degree
in Accounting and Computer Science from Oregon State University. Profile
Mr. Simpson: Targeted Genetics is developing molecular medicines, or
gene-based therapies to treat both acquired and inherited
